Reply on "teriparatide treatment for postmenopausal women with sacral insufficiency fracture".
作者信息
Yang Yao-Chun, Hsieh Min-Hong, Chien Jui-Teng, Liu Keng-Chang, Yang Chang-Chen
机构信息
National Taiwan University School of Medicine, Taiwan.
Department of Orthopedics, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, 62247, Taiwan.
出版信息
Osteoporos Sarcopenia. 2023 Jun;9(2):77. doi: 10.1016/j.afos.2023.05.004. Epub 2023 Jun 17.
Abstract
摘要
相似文献
1
Reply on "teriparatide treatment for postmenopausal women with sacral insufficiency fracture".
Osteoporos Sarcopenia. 2023 Jun;9(2):77. doi: 10.1016/j.afos.2023.05.004. Epub 2023 Jun 17.
2
Teriparatide treatment shows faster healing than sacroplasty for postmenopausal women with sacral insufficiency fracture.
Osteoporos Sarcopenia. 2023 Mar;9(1):27-31. doi: 10.1016/j.afos.2023.02.001. Epub 2023 Feb 15.
3
Teriparatide treatment for postmenopausal women with sacral insufficiency fracture.
Osteoporos Sarcopenia. 2023 Jun;9(2):76. doi: 10.1016/j.afos.2023.05.003. Epub 2023 Jun 23.
4
Teriparatide Treatment in Elderly Patients With Sacral Insufficiency Fracture.
J Clin Endocrinol Metab. 2017 Feb 1;102(2):560-565. doi: 10.1210/jc.2016-3582.
5
[Teriparatide as a therapy approach in sacral insufficiency fractures].
Unfallchirurg. 2017 Nov;120(11):1000-1003. doi: 10.1007/s00113-017-0400-8.
6
Enhanced bone healing and decreased pain in sacral insufficiency fractures after teriparatide treatment: retrospective clinical-based observational study.
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):140-145. doi: 10.11138/ccmbm/2017.14.1.140. Epub 2017 Oct 25.
7
Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
J Bone Joint Surg Am. 2009 Jun;91(6):1329-38. doi: 10.2106/JBJS.H.01030.
8
Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.
Arch Intern Med. 2004 Oct 11;164(18):2024-30. doi: 10.1001/archinte.164.18.2024.
9
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
Osteoporos Int. 2024 Jul;35(7):1173-1183. doi: 10.1007/s00198-024-07043-2. Epub 2024 Apr 2.
10
The Fracture Incidence and Safety of Teriparatide and Bisphosphonate in Postmenopausal Women With Osteoporosis: A Meta-Analysis.
Altern Ther Health Med. 2024 Aug;30(8):258-263.
本文引用的文献
1
Teriparatide treatment for postmenopausal women with sacral insufficiency fracture.
Osteoporos Sarcopenia. 2023 Jun;9(2):76. doi: 10.1016/j.afos.2023.05.003. Epub 2023 Jun 23.
2
Sacroplasty: A Ten-Year Analysis of Prospective Patients Treated with Percutaneous Sacroplasty: Literature Review and Technical Considerations.
Pain Physician. 2017 Nov;20(7):E1063-E1072.
3
Effects of Percutaneous Sacroplasty on Pain and Mobility in Sacral Insufficiency Fracture.
J Korean Neurosurg Soc. 2017 Jan 1;60(1):60-66. doi: 10.3340/jkns.2016.0505.010. Epub 2016 Dec 29.
4
Complications related to cement leakage in sacroplasty.
Acta Orthop Belg. 2012 Feb;78(1):100-5.
5
Teriparatide improves early callus formation in distal radial fractures.
Acta Orthop. 2010 Apr;81(2):234-6. doi: 10.3109/17453671003761946.
6
Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism.
J Orthop Res. 2007 Nov;25(11):1454-64. doi: 10.1002/jor.20433.
7
Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.
Bone. 2007 Jun;40(6):1475-82. doi: 10.1016/j.bone.2007.01.015. Epub 2007 Feb 2.
Zotero 插件